ScinoPharm Taiwan, Ltd. (TPE:1789)

ScinoPharm Taiwan Revenue

In the year 2024, ScinoPharm Taiwan had annual revenue of 3.41B TWD with 6.91% growth. ScinoPharm Taiwan had revenue of 1.04B in the quarter ending December 31, 2024, a decrease of -7.72%.

• Revenue: 3.41B
• Revenue Growth: +6.91%
• P/S Ratio: 5.35
• Revenue / Employee: 6.31M
• Employees: 540
• Market Cap: 18.27B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.41B	220.20M	6.91%
Dec 31, 2023	3.19B	-77.96M	-2.39%
Dec 31, 2022	3.26B	501.71M	18.16%
Dec 31, 2021	2.76B	-320.59M	-10.40%
Dec 31, 2020	3.08B	190.15M	6.57%